UnitedHealthcare
Braftovi (encorafenib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy Applies
  • Quantity Limit: limit maximum 6 EA PER 1 day(s)
  • Prior Authorization: Colorectal Cancer:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Melanoma (MEL):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Orally administered anticancer medication.
  • Colorectal Cancer:
    Duration: 12 Month(s)
    Documented Diagnosis Requirement: Explicitly Documented
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Drug Policy Based On: Payer Specific
    Documented Diagnosis: Yes
    Specialty Pharmacy is Required: Not Defined

    Melanoma (MEL):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)